Labcorp said its executive management team will take part in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 15 at 11:30 a.m. ET.
The company said the event comes as it continues to operate at scale, with nearly 71,000 employees serving clients in about 100 countries. Labcorp said it supported more than 85% of the new drugs and therapeutic products approved by the FDA in 2025 and performed more than 750 million tests for patients worldwide. As a result of these announcements, the company's shares have moved 0.05% on the market, and are now trading at a price of $336.71. For the full picture, make sure to review LABCORP HOLDINGS INC.'s 8-K report.
